Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
Advanced Laser Vision and Surgical Institute
991
mi
from 43215
Houston, TX
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
Advanced Laser Vision and Surgical Institute
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
University of Houston, College of Optometry
992
mi
from 43215
Houston, TX
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
University of Houston, College of Optometry
992
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
Whitsett Vision Group
994
mi
from 43215
Houston, TX
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
Whitsett Vision Group
994
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
The Eye Clinic of Texas (Houston Eye Associates)
993
mi
from 43215
League City, TX
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
The Eye Clinic of Texas (Houston Eye Associates)
993
mi
from 43215
League City, TX
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
Eye Clinics of South Texas
1135
mi
from 43215
San Antonio, TX
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
Eye Clinics of South Texas
1135
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
R and R Eye Research, LLC
1138
mi
from 43215
San Antonio, TX
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
R and R Eye Research, LLC
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
See Clearly Vision
319
mi
from 43215
McLean, VA
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
See Clearly Vision
319
mi
from 43215
McLean, VA
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
Tekwani Vision Center
405
mi
from 43215
Saint Louis, MO
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
Tekwani Vision Center
405
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated:  12/31/1969
Ophthalmology Consultants Ltd
408
mi
from 43215
Saint Louis, MO
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
A Phase 3, Multicenter, Randomized, Double-masked, and Placebo-controlled Study Evaluating the Efficacy and Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease and History of Recent Artificial Tear Use
Status: Enrolling
Updated: 12/31/1969
Ophthalmology Consultants Ltd
408
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1967
mi
from 43215
Huntington Beach, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1967
mi
from 43215
Huntington Beach, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1975
mi
from 43215
Long Beach, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1975
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2090
mi
from 43215
Napa, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2090
mi
from 43215
Napa, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2105
mi
from 43215
Redwood City, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2105
mi
from 43215
Redwood City, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2028
mi
from 43215
Roseville, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2028
mi
from 43215
Roseville, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2083
mi
from 43215
Walnut Creek, CA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2083
mi
from 43215
Walnut Creek, CA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
533
mi
from 43215
Waterbury, CT
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
533
mi
from 43215
Waterbury, CT
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
661
mi
from 43215
Tallahassee, FL
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
661
mi
from 43215
Tallahassee, FL
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
831
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
448
mi
from 43215
Stockbridge, GA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
448
mi
from 43215
Stockbridge, GA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
316
mi
from 43215
Normal, IL
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
316
mi
from 43215
Normal, IL
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
380
mi
from 43215
Shiloh, IL
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
380
mi
from 43215
Shiloh, IL
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
280
mi
from 43215
Evansville, IN
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
280
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
266
mi
from 43215
Owensboro, KY
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
266
mi
from 43215
Owensboro, KY
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
798
mi
from 43215
Bangor, ME
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
798
mi
from 43215
Bangor, ME
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
323
mi
from 43215
Bethesda, MD
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
323
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
315
mi
from 43215
Gaithersburg, MD
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
315
mi
from 43215
Gaithersburg, MD
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
642
mi
from 43215
Brockton, MA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
642
mi
from 43215
Brockton, MA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
624
mi
from 43215
Minneapolis, MN
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
635
mi
from 43215
Plymouth, MN
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
635
mi
from 43215
Plymouth, MN
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
679
mi
from 43215
Bellevue, NE
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
679
mi
from 43215
Bellevue, NE
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
477
mi
from 43215
Teaneck, NJ
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
477
mi
from 43215
Teaneck, NJ
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
465
mi
from 43215
Verona, NJ
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
465
mi
from 43215
Verona, NJ
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
355
mi
from 43215
Rochester, NY
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
496
mi
from 43215
Rockville Centre, NY
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
496
mi
from 43215
Rockville Centre, NY
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
322
mi
from 43215
High Point, NC
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
322
mi
from 43215
High Point, NC
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
103
mi
from 43215
Canton, OH
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
103
mi
from 43215
Canton, OH
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2058
mi
from 43215
Medford, OR
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2058
mi
from 43215
Medford, OR
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
405
mi
from 43215
Bethlehem, PA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
405
mi
from 43215
Bethlehem, PA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
409
mi
from 43215
Blue Bell, PA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
409
mi
from 43215
Blue Bell, PA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
619
mi
from 43215
Providence, RI
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1137
mi
from 43215
Kerrville, TX
Phase II HDM-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1137
mi
from 43215
Kerrville, TX
Click here to add this to my saved trials